Regulatory considerations for paediatric drug evaluation in China

The regulatory guidelines for the research and development of paediatric drugs are still evolving in China. The formulation of the guidelines started from learning and borrowing existing experience, and gradually changed to the exploration and improvement of local guidelines, which was not only in l...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Ying, Li, Qiang, Sun, Yan-Zhe, Zhang, Hao, Jiang, Yong-Lin, Wang, Li-Qing, Wu, Yue-E, Zhao, Wei, Yang, Zhi-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163445/
https://www.ncbi.nlm.nih.gov/pubmed/37130653
http://dx.doi.org/10.1136/bmjpo-2022-001666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163445/
https://www.ncbi.nlm.nih.gov/pubmed/37130653
http://dx.doi.org/10.1136/bmjpo-2022-001666

Ejemplares similares